Skip to main content
. Author manuscript; available in PMC: 2012 Feb 29.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Oct;55(2):189–196. doi: 10.1097/QAI.0b013e3181e46308

Figure 3.

Figure 3

Comparison of serum and salivary influenza-specific antibodies in HIV-infected LAIV recipients who excreted ≥1 vaccine viruses (shedders) or did not (non-shedders). Data were derived from 109 HIV-infected children on HAART who received LAIV 2004/2005 and had baseline antibody measurements. There were 22 influenza A H1N1 New Caledonia, 9 B Jilin and 3 A H3N2 Wyoming shedders. For the salivary influenza-IgG and IgA analyses, all shedders were analyzed together irrespective of the type of virus they shed. The F test was used for the statistical analysis.